Argus Research Maintains Buy on Exelon, Lowers Price Target to $49

Benzinga Newsdesk www.benzinga.com Negative 70.5%

Neg 70.5% Neu 0% Pos 0%

Argus Research analyst Marie Ferguson maintains Exelon (NASDAQ:EXC) with a Buy and lowers the price target from $52 to $49.